{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:36:45Z","timestamp":1789475805421,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"DOI":"10.7759\/cureus.67901","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:00:26Z","timestamp":1724752826000},"source":"Crossref","is-referenced-by-count":5,"title":["A Voyage on the Role of Nuclear Factor Kappa B (NF-kB) Signaling Pathway in Duchenne Muscular Dystrophy: An Inherited Muscle Disorder"],"prefix":"10.7759","author":[{"given":"Akshaya","family":"R","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Vellapandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart IE","year":"2019","unstructured":"Verhaart IE, Aartsma-Rus A. Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol. 2019, 15:373-86. 10.1038\/s41582-019-0203-3","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.12868","article-title":"Duchenne muscular dystrophy","volume":"51","author":"Yiu EM","year":"2015","unstructured":"Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. J Paediatr Child Health. 2015, 51:759-64. 10.1111\/jpc.12868","journal-title":"J Paediatr Child Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/genes11080837","article-title":"Therapeutic strategies for Duchenne muscular dystrophy: An update","volume":"11","author":"Sun C","year":"2020","unstructured":"Sun C, Shen L, Zhang Z, Xie X. Therapeutic strategies for Duchenne muscular dystrophy: An update. Genes. 2020, 11:837. 10.3390\/genes11080837","journal-title":"Genes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091686","article-title":"Inflammation: Roles in skeletal muscle atrophy","volume":"11","author":"Ji Y","year":"2022","unstructured":"Ji Y, Li M, Chang M, et al.. Inflammation: Roles in skeletal muscle atrophy. Antioxidants. 2022, 11:1686. 10.3390\/antiox11091686","journal-title":"Antioxidants"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03821-x","article-title":"Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy","volume":"78","author":"Starosta A","year":"2021","unstructured":"Starosta A, Konieczny P. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci. 2021, 78:4867-91. 10.1007\/s00018-021-03821-x","journal-title":"Cell Mol Life Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.08.004","article-title":"The DMD gene and therapeutic approaches to restore dystrophin","volume":"31","author":"Fortunato F","year":"2021","unstructured":"Fortunato F, Farn\u00e8 M, Ferlini A. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscul Disord. 2021, 31:1013-20. 10.1016\/j.nmd.2021.08.004","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan D","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021, 7:13. 10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jpm9010016","article-title":"Mutation-based therapeutic strategies for Duchenne muscular dystrophy: From genetic diagnosis to therapy","volume":"9","author":"Nakamura A","year":"2019","unstructured":"Nakamura A. Mutation-based therapeutic strategies for Duchenne muscular dystrophy: From genetic diagnosis to therapy. J Pers Med. 2019, 9:16. 10.3390\/jpm9010016","journal-title":"J Pers Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: Myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds MD","year":"2020","unstructured":"Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG. Biomarkers for Duchenne muscular dystrophy: Myonecrosis, inflammation and oxidative stress. Dis Model Mech. 2020, 13:dmm043638. 10.1242\/dmm.043638","journal-title":"Dis Model Mech"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in Duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar A","year":"2021","unstructured":"Tulangekar A, Sztal TE. Inflammation in Duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration. Biomedicines. 2021, 9:1366. 10.3390\/biomedicines9101366","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101447","article-title":"The immune system in Duchenne muscular dystrophy pathogenesis","volume":"9","author":"Tripodi L","year":"2021","unstructured":"Tripodi L, Villa C, Molinaro D, Torrente Y, Farini A. The immune system in Duchenne muscular dystrophy pathogenesis. Biomedicines. 2021, 9:1447. 10.3390\/biomedicines9101447","journal-title":"Biomedicines"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-016-0019-0","article-title":"Inflammatory predisposition predicts disease phenotypes in muscular dystrophy","volume":"36","author":"Nitahara-Kasahara Y","year":"2016","unstructured":"Nitahara-Kasahara Y, Takeda S, Okada T. Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflamm Regen. 2016, 36:14. 10.1186\/s41232-016-0019-0","journal-title":"Inflamm Regen"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12461","article-title":"Cilostazol attenuates oxidative stress and apoptosis in the quadriceps muscle of the dystrophic mouse experimental model","volume":"104","author":"Hermes TA","year":"2023","unstructured":"Hermes TA, M\u00e2ncio RD, Mizobutti DS, Macedo AB, Kido LA, Cagnon Quitete VH, Minatel E. Cilostazol attenuates oxidative stress and apoptosis in the quadriceps muscle of the dystrophic mouse experimental model. Int J Exp Pathol. 2023, 104:13-22. 10.1111\/iep.12461","journal-title":"Int J Exp Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10974-012-9330-9","article-title":"Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy","volume":"34","author":"Kim JH","year":"2013","unstructured":"Kim JH, Kwak HB, Thompson LV, Lawler JM. Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy. J Muscle Res Cell Motil. 2013, 34:1-13. 10.1007\/s10974-012-9330-9","journal-title":"J Muscle Res Cell Motil"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265879","article-title":"Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis","volume":"17","author":"Ferizovic N","year":"2022","unstructured":"Ferizovic N, Summers J, de Z\u00e1rate IB, Werner C, Jiang J, Landfeldt E, Buesch K. Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis. PLoS One. 2022, 17:e0265879. 10.1371\/journal.pone.0265879","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511900","article-title":"Alternations of NF-\u03baB signaling by natural compounds in muscle-derived cancers","volume":"24","author":"Radzka J","year":"2023","unstructured":"Radzka J, \u0141api\u0144ska Z, Szwedowicz U, Gajewska-Naryniecka A, Gizak A, Kulbacka J.  Alternations of NF-\u03baB signaling by natural compounds in muscle-derived cancers. Int J Mol Sci. 2023, 24:11900. 10.3390\/ijms241511900","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081906","article-title":"Role of NF-\u03baB in ageing and age-related diseases: Lessons from genetically modified mouse models","volume":"10","author":"Garc\u00eda-Garc\u00eda VA","year":"2021","unstructured":"Garc\u00eda-Garc\u00eda VA, Alameda JP, Page A, Casanova ML. Role of NF-\u03baB in ageing and age-related diseases: Lessons from genetically modified mouse models. Cells. 2021, 10:1906. 10.3390\/cells10081906","journal-title":"Cells"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: At the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei L","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R. NF-\u03baB: At the borders of autoimmunity and inflammation. Front Immunol. 2021, 12:716469. 10.3389\/fimmu.2021.716469","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082042","article-title":"The transcription factor NF-\u03baB in stem cells and development","volume":"10","author":"Kaltschmidt C","year":"2021","unstructured":"Kaltschmidt C, Greiner JF, Kaltschmidt B. The transcription factor NF-\u03baB in stem cells and development. Cells. 2021, 10:2042. 10.3390\/cells10082042","journal-title":"Cells"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-021-10172-4","article-title":"Three-dimensional spheroid culture enhances multipotent differentiation and stemness capacities of human dental pulp\u2010derived mesenchymal stem cells by modulating MAPK and NF-kB signaling pathways","volume":"17","author":"Chan YH","year":"2021","unstructured":"Chan YH, Lee YC, Hung CY, Yang PJ, Lai PC, Feng SW. Three-dimensional spheroid culture enhances multipotent differentiation and stemness capacities of human dental pulp\u2010derived mesenchymal stem cells by modulating MAPK and NF-kB signaling pathways. Stem Cell Rev Rep. 2021, 17:1810-26. 10.1007\/s12015-021-10172-4","journal-title":"Stem Cell Rev Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1538-9","article-title":"Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway","volume":"16","author":"Zusso M","year":"2019","unstructured":"Zusso M, Lunardi V, Franceschini D, et al.. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway. J Neuroinflammation. 2019, 16:148. 10.1186\/s12974-019-1538-9","journal-title":"J Neuroinflammation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: New insights and translational implications","volume":"9","author":"Guo Q","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, et al.. NF-\u03baB in biology and targeted therapy: New insights and translational implications. Signal Transduct Target Ther. 2024, 9:53. 10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li Q","year":"2002","unstructured":"Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002, 2:725-34. 10.1038\/nri910","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12720","article-title":"Progranulin promotes osteogenic differentiation of human periodontal ligament stem cells via tumor necrosis factor receptors to inhibit TNF-\u03b1 sensitized NF-kB and activate ERK\/JNK signaling","volume":"55","author":"Chen J","year":"2020","unstructured":"Chen J, Yu M, Li X, Sun QF, Yang CZ, Yang PS. Progranulin promotes osteogenic differentiation of human periodontal ligament stem cells via tumor necrosis factor receptors to inhibit TNF-\u03b1 sensitized NF-kB and activate ERK\/JNK signaling. J Periodontal Res. 2020, 55:363-73. 10.1111\/jre.12720","journal-title":"J Periodontal Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.07.004","article-title":"Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities","volume":"224","author":"Yu X","year":"2019","unstructured":"Yu X, Zhang F, Shi J. Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities. Immunobiology. 2019, 224:638-44. 10.1016\/j.imbio.2019.07.004","journal-title":"Immunobiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110916","article-title":"Regulatory role of NF-\u03baB in growth plate chondrogenesis and its functional interaction with growth hormone","volume":"514","author":"De Luca F","year":"2020","unstructured":"De Luca F. Regulatory role of NF-\u03baB in growth plate chondrogenesis and its functional interaction with growth hormone. Mol Cell Endocrinol. 2020, 514:110916. 10.1016\/j.mce.2020.110916","journal-title":"Mol Cell Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100964","article-title":"The impact of mitochondrial deficiencies in neuromuscular diseases","volume":"9","author":"Cant\u00f3-Santos J","year":"2020","unstructured":"Cant\u00f3-Santos J, Grau-Junyent JM, Garrabou G. The impact of mitochondrial deficiencies in neuromuscular diseases. Antioxidants. 2020, 9:964. 10.3390\/antiox9100964","journal-title":"Antioxidants"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1035709","article-title":"The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy","volume":"13","author":"Liu Y","year":"2022","unstructured":"Liu Y, Wang D, Li T, Yang F, Li Z, Bai X, Wang Y. The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy. Front Immunol. 2022, 13:1035709. 10.3389\/fimmu.2022.1035709","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00403","article-title":"PTX3 predicts myocardial damage and fibrosis in Duchenne muscular dystrophy","volume":"11","author":"Farini A","year":"2020","unstructured":"Farini A, Villa C, Di Silvestre D, et al.. PTX3 predicts myocardial damage and fibrosis in Duchenne muscular dystrophy. Front Physiol. 2020, 11:403. 10.3389\/fphys.2020.00403","journal-title":"Front Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00040.2009","article-title":"NF-kappaB signaling: a tale of two pathways in skeletal myogenesis","volume":"90","author":"Bakkar N","year":"2010","unstructured":"Bakkar N, Guttridge DC. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev. 2010, 90:495-511. 10.1152\/physrev.00040.2009","journal-title":"Physiol Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134596","article-title":"Anti-inflammatory and general glucocorticoid physiology in skeletal muscles affected by Duchenne muscular dystrophy: Exploration of steroid-sparing agents","volume":"21","author":"Herbelet S","year":"2020","unstructured":"Herbelet S, Rodenbach A, Paepe B, De Bleecker JL. Anti-inflammatory and general glucocorticoid physiology in skeletal muscles affected by Duchenne muscular dystrophy: Exploration of steroid-sparing agents. Int J Mol Sci. 2020, 21:4596. 10.3390\/ijms21134596","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.689533","article-title":"Current pharmacological strategies for Duchenne muscular dystrophy","volume":"9","author":"Yao S","year":"2021","unstructured":"Yao S, Chen Z, Yu Y, et al.. Current pharmacological strategies for Duchenne muscular dystrophy. Front Cell Dev Biol. 2021, 9:689533. 10.3389\/fcell.2021.689533","journal-title":"Front Cell Dev Biol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1030785","article-title":"A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy","volume":"13","author":"Botti V","year":"2022","unstructured":"Botti V, Menzel O, Staedler D. A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy. Front Pharmacol. 2022, 13:1030785. 10.3389\/fphar.2022.1030785","journal-title":"Front Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1732350","article-title":"New and emerging pharmacotherapy for Duchenne muscular dystrophy: A focus on synthetic therapeutics","volume":"21","author":"Grages SM","year":"2020","unstructured":"Grages SM, Bell M, Berlau DJ. New and emerging pharmacotherapy for Duchenne muscular dystrophy: A focus on synthetic therapeutics. Expert Opin Pharmacother. 2020, 21:841-51. 10.1080\/14656566.2020.1732350","journal-title":"Expert Opin Pharmacother"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.606069","article-title":"The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4\/NF-\u03baB-mediated inflammation","volume":"12","author":"Saleh HA","year":"2021","unstructured":"Saleh HA, Yousef MH, Abdelnaser A. The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4\/NF-\u03baB-mediated inflammation. Front Immunol. 2021, 12:606069. 10.3389\/fimmu.2021.606069","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.10.001","article-title":"Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead","volume":"31","author":"Heslop E","year":"2021","unstructured":"Heslop E, Turner C, Irvin A, Muntoni F, Straub V, Guglieri M. Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead. Neuromuscul Disord. 2021, 31:69-78. 10.1016\/j.nmd.2020.10.001","journal-title":"Neuromuscul Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/1367493519857423","article-title":"Health-related quality of life in Chinese boys with Duchenne muscular dystrophy and their families","volume":"23","author":"Liang R","year":"2019","unstructured":"Liang R, Chan SH, Ho FK, Tang OC, Cherk SW, Ip P, Lau EY. Health-related quality of life in Chinese boys with Duchenne muscular dystrophy and their families. J Child Health Care. 2019, 23:495-506. 10.1177\/1367493519857423","journal-title":"J Child Health Care"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02674-w","article-title":"Toward patient-centered treatment goals for Duchenne muscular dystrophy: Insights from the \"Your Voice\" study","volume":"18","author":"Schwartz CE","year":"2023","unstructured":"Schwartz CE, Jackson S, Valentine J, et al.. Toward patient-centered treatment goals for Duchenne muscular dystrophy: Insights from the \"Your Voice\" study. Orphanet J Rare Dis. 2023, 18:90. 10.1186\/s13023-023-02674-w","journal-title":"Orphanet J Rare Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14129","article-title":"A new era in the management of Duchenne muscular dystrophy","volume":"61","author":"Korinthenberg R","year":"2019","unstructured":"Korinthenberg R. A new era in the management of Duchenne muscular dystrophy. Dev Med Child Neurol. 2019, 61:292-7. 10.1111\/dmcn.14129","journal-title":"Dev Med Child Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant DJ","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018, 17:347-61. 10.1016\/S1474-4422(18)30025-5","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant DJ","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018, 17:251-67. 10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-018-3555-3","article-title":"Clinical management of Duchenne muscular dystrophy: The state of the art","volume":"39","author":"Messina S","year":"2018","unstructured":"Messina S, Vita GL. Clinical management of Duchenne muscular dystrophy: The state of the art. Neurol Sci. 2018, 39:1837-45. 10.1007\/s10072-018-3555-3","journal-title":"Neurol Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0333G","article-title":"Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Brumbaugh D","year":"2018","unstructured":"Brumbaugh D, Watne L, Gottrand F, Gulyas A, Kaul A, Larson J, Tomezsko J. Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018, 142:S53-61. 10.1542\/peds.2018-0333G","journal-title":"Pediatrics"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/nu9060594","article-title":"Nutritional challenges in Duchenne muscular dystrophy","volume":"9","author":"Salera S","year":"2017","unstructured":"Salera S, Menni F, Moggio M, Guez S, Sciacco M, Esposito S. Nutritional challenges in Duchenne muscular dystrophy. Nutrients. 2017, 9:594. 10.3390\/nu9060594","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v12.i4.197","article-title":"Gastrointestinal and nutritional care in pediatric neuromuscular disorders","volume":"12","author":"Dipasquale V","year":"2023","unstructured":"Dipasquale V, Morello R, Romano C. Gastrointestinal and nutritional care in pediatric neuromuscular disorders. World J Clin Pediatr. 2023, 12:197-204. 10.5409\/wjcp.v12.i4.197","journal-title":"World J Clin Pediatr"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedn.2021.08.003","article-title":"Emergency planning as part of healthcare transition preparation for patients with Duchenne muscular dystrophy","volume":"61","author":"Chouteau WA","year":"2021","unstructured":"Chouteau WA, Burrows C, Wittekind SG, et al.. Emergency planning as part of healthcare transition preparation for patients with Duchenne muscular dystrophy. J Pediatr Nurs. 2021, 61:298-304. 10.1016\/j.pedn.2021.08.003","journal-title":"J Pediatr Nurs"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant DJ","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018, 17:445-55. 10.1016\/S1474-4422(18)30026-7","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276030-a-voyage-on-the-role-of-nuclear-factor-kappa-b-nf-kb-signaling-pathway-in-duchenne-muscular-dystrophy-an-inherited-muscle-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:00:30Z","timestamp":1724752830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276030-a-voyage-on-the-role-of-nuclear-factor-kappa-b-nf-kb-signaling-pathway-in-duchenne-muscular-dystrophy-an-inherited-muscle-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.67901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}